PUBLISHER: IMARC | PRODUCT CODE: 1541255
PUBLISHER: IMARC | PRODUCT CODE: 1541255
The global airway management devices market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032.
Airway management devices are utilized for maintaining or restoring ventilation in a patient. It also involves evaluating, planning, and using different medical procedures to treat patients with respiratory failures or acute obstruction. Besides this, it protects the lungs from injury and provides gas exchange facilities to the patients. Some of the commonly used airway management devices to keep the upper airway open for offering unobstructed ventilation are supraglottic airway devices (SADs), tracheal intubation, transtracheal access, airway clearance.
The increasing prevalence of respiratory diseases represents one of the key factors driving the market. Additionally, on account of the growing number of surgeries, there is a rise in the utilization of anesthesia. This, in confluence with numerous benefits of airway management devices, such as the high efficiency in airway clearance and maintenance of proper ventilation and patient safety during operative procedures, is also contributing to the market growth. Besides this, an increase in the emergency treatment of prolonged illness and protracted treatment associated with lung diseases in children and adults is catalyzing the demand for airway management devices. Furthermore, the advent of advanced techniques for preoperative airway evaluation is also strengthening the market growth. For instance, Preoperative Endoscopic Airway Evaluation (PEAE) is a technique that identifies, predicts the blocked ventilation, and facilitates a plan for efficient management, which particularly involves the usage of advanced devices, such as supraglottic airway. These airway devices provide easy tracheal placement resulting in improved patient safety, and are subsequently utilized in a range of clinical applications.
IMARC Group provides an analysis of the key trends in each sub-segment of the global airway management devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, patient type, application and end use.
Supraglottic Devices
Oropharyngeal Devices
Naspharyngeal Devices
Laryngeal Airway Devices
Others
Infraglottic Devices
Endotracheal Tubes
Tracheostomy Tubes
Others
Resuscitators
Laryngoscopes
Others
Adult
Pediatric Patient/Neonates
Anesthesia
Emergency Medicine
Others
Hospitals
Homecare
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ambu A/S, Armstrong Medical Ltd., Becton Dickinson and Company, Flexicare (Group) Limited, Intersurgical Ltd., Medline Industries Inc, Medtronic plc, Mercury Enterprises Inc., Smiths Group plc, Teleflex Incorporated, VBM Medizintechnik GmbH and Verathon Inc. (Roper Technologies Inc.).